Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1208, 2008-01, pp. : 28-28
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sorafenib: Tumour lysis: case report
Reactions Weekly, Vol. 1, Iss. 1316, 2010-01 ,pp. :
Sorafenib: Fatal tumour lysis syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. :
Sorafenib: Tumour lysis syndrome in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1332, 2010-01 ,pp. :
Nilotinib: First report of tumour lysis syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1193, 2008-01 ,pp. :
Bevacizumab: Tumour lysis syndrome (first report) in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1190, 2008-01 ,pp. :